Senate Committee Advanced Two HHS Nominations

The Senate Finance Committee voted to advance the nominations of Chris Klomp and Ge Bai for key posts at HHS.

Updated on Sept. 24, 2026 in People

Bold flat-color editorial illustration of a neoclassical legislative dais, navy and cream, evoking the institutional gravity of the federal confirmation process.
The Senate Finance Committee voted to advance the HHS nominations of Chris Klomp and Ge Bai, moving the candidates toward full Senate confirmation. AI Illustration. Upload story photo >

Live Poll

Should political appointees prioritize departmental policy over the direct orders of the president?

The Senate Finance Committee approved the nominations of Chris Klomp as deputy secretary of health and human services and Ge Bai as assistant secretary for planning and evaluation. The nominations will now proceed to the full Senate for final confirmation votes.

Why it matters

These appointments are critical for filling key leadership roles within the Department of Health and Human Services as it navigates complex healthcare policy oversight. Advancing these candidates signifies a key step in the formal Senate confirmation process for the current administration.

The committee advanced the nomination of Chris Klomp with a 15-12 vote and Ge Bai with a 14-13 vote. These figures represent the narrow margins by which the candidates moved forward to the full Senate floor.

The players

Chris Klomp

He is a nominee for the position of deputy secretary of health and human services and previously served as the CEO of health IT company Collective Medical.

Ge Bai

She is a nominee for the role of assistant secretary for planning and evaluation at the Department of Health and Human Services.

Robert F. Kennedy Jr.

He is the current Secretary of Health and Human Services.

The details

The committee action follows testimony provided by Chris Klomp, who currently serves as a senior adviser to HHS Secretary Robert F. Kennedy Jr. Klomp, formerly the CEO of health IT firm Collective Medical, previously appeared before the Senate Finance and HELP committees to discuss his qualifications and future responsibilities.

Timeline

  1. Chris Klomp testified before the Senate Finance and HELP committees from September 17-18, 2026.

  2. The Senate Finance committee voted to advance the nominations on September 24, 2026.

Market Landscape

These appointments reflect the ongoing consolidation of leadership within the Department of Health and Human Services as it manages high-stakes federal health policy. This shift positions the agency to address long-term operational challenges and regulatory priorities under the current administration.

The confirmation of these officials will determine the long-term direction of federal healthcare policies and agency management. Consumers and stakeholders should monitor these appointments for potential impacts on how HHS oversees public health initiatives and healthcare delivery programs.

The takeaway

The advancement of these nominees highlights the active role of the Senate in vetting executive appointments. Keeping track of these leadership changes is essential for understanding how the federal government plans to manage health policy and service delivery in the coming years.

Further reading

For additional context on administrative appointments, visit People.

Live Poll

Should political appointees prioritize departmental policy over the direct orders of the president?